|Last Price$58.86||Day Change (%)0.34%|
|Open Price$58.49||Day Change ($)0.20|
|Day Range58.20–59.06||52-Week Range52.08–62.55|
As of Mon 6/27/2016 7:02:00 PM | USD
FLIXABI®, Biogen’s Infliximab Biosimilar Referencing Remicade®, Approved in the European Union
PPs are generally averse to taking on additional risk in their portfolio, which makes accounting for SLR a somewhat easier task.
The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...
Passive Preservers place a great deal of emphasis on financial security and preserving wealth.
When to maintain a rational asset allocation and when to give in to behavioral biases.
Here's our attempt to connect behavioral finance theory with real investors.
More results from our attempt to connect real people with behavioral finance theory.